Cardiomyopathies: The Diversity of the Diagnosis

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

The term cardiomyopathy may be confusing. Each type of cardiomyopathy impacts myocardial performance differently, requiring specific treatment strategies to impact outcomes. This session guides the learner to a new understanding of the differences between dilated, restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies as well as up-to-date knowledge regarding new treatment options for patients with amyloidosis and hypertrophic cardiomyopathy.

Objectives

Identify the pathophysiologic differences between dilated, restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
Differentiate clinical presentations associated with dilated, restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
Discuss treatment options for the patient with dilated, restrictive, , hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.